Ranbaxy Demands Website Stop Selling Lipitor Generic In U.S.

Law360, New York (April 14, 2004, 12:00 AM EDT) -- Ranbaxy has weighed in on Pfizer’s lawsuit against a website that sells a generic version of blockbuster cholesterol fighter Lipitor, demanding that the vendor stops selling generic drugs that have not been approved for sale in the United States.

The Indian drug maker said it does not recognize or endorse the internet pharmacy look4generics (http://www.look4generics.com), which is targeted by Pfizer’s lawsuit.

Pfizer’s lawsuit, filed Monday in U. S. District Court in Delaware, seeks an injunction against further sales of the drug and claims infringement of Pfizer's...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.